1. Home
  2. MATH vs TTRX Comparison

MATH vs TTRX Comparison

Compare MATH & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Metalpha Technology Holding Limited

MATH

Metalpha Technology Holding Limited

N/A

Current Price

$1.19

Market Cap

52.1M

Sector

Finance

ML Signal

N/A

TTRX

Turn Therapeutics Inc.

N/A

Current Price

$3.50

Market Cap

116.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MATH
TTRX
Founded
2015
2015
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.1M
116.0M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
MATH
TTRX
Price
$1.19
$3.50
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$8.00
AVG Volume (30 Days)
72.5K
13.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.10
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.10
$2.57
52 Week High
$4.17
$5.98

Technical Indicators

Market Signals
Indicator
MATH
TTRX
Relative Strength Index (RSI) 36.81 45.53
Support Level $1.10 $2.64
Resistance Level $3.16 $4.01
Average True Range (ATR) 0.07 0.20
MACD 0.04 0.02
Stochastic Oscillator 50.00 35.90

Price Performance

Historical Comparison
MATH
TTRX

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and generates majority of its revenue from Hong Kong.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology company focused on developing pharmaceutical and medical device products for dermatology, wound care, and infectious disease. The company's proprietary platform technology, called PermaFusion, enhances drug performance by improving the stability and bioavailability of active pharmaceutical ingredients, which allows for reduced doses and fewer side effects. Its primary development programs target skin conditions such as moderate to severe eczema and onychomycosis.

Share on Social Networks: